H.C. Wainwright analyst Yi Chen raised the firm’s price target on Oculis (OCS) to $42 from $36 and keeps a Buy rating on the shares following the Q3 report. The firm says the company’s PIONEER registrational program targets an untapped market opportunity of over $7B.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCS:
- Oculis Holding: Promising Pipeline Developments and Strong Financial Position Support Buy Rating
- Oculis Holding AG Reports Q3 2025 Financial Progress
- Oculis files to sell 494K ordinary shares for holders
- Oculis reports Q3 EPS (32c), consensus (41c)
- Oculis Holding AG Reports Q3 2025 Financial Results
